Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.
Juergens A, Pels H, Rogowski S, Fliessbach K, Glasmacher A, Engert A, Reiser M, Diehl V, Vogt-Schaden M, Egerer G, Schackert G, Reichmann H, Kroschinsky F, Bode U, Herrlinger U, Linnebank M, Deckert M, Fimmers R, Schmidt-Wolf IG, Schlegel U. Juergens A, et al. Among authors: vogt schaden m. Ann Neurol. 2010 Feb;67(2):182-9. doi: 10.1002/ana.21824. Ann Neurol. 2010. PMID: 20225195
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U. Pels H, et al. J Clin Oncol. 2003 Dec 15;21(24):4489-95. doi: 10.1200/JCO.2003.04.056. Epub 2003 Nov 3. J Clin Oncol. 2003. PMID: 14597744 Clinical Trial.
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study.
Pels H, Juergens A, Glasmacher A, Schulz H, Engert A, Linnebank M, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Lamprecht M, Hau P, Deckert M, Fimmers R, Bangard C, Schmidt-Wolf IG, Schlegel U. Pels H, et al. Among authors: vogt schaden m. J Neurooncol. 2009 Feb;91(3):299-305. doi: 10.1007/s11060-008-9712-4. Epub 2008 Oct 18. J Neurooncol. 2009. PMID: 18931887 Free article. Clinical Trial.
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma.
Pels H, Juergens A, Schirgens I, Glasmacher A, Schulz H, Engert A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Deckert M, Fimmers R, Urbach H, Schmidt-Wolf IG, Schlegel U. Pels H, et al. Among authors: vogt schaden m. Neuro Oncol. 2010 Jul;12(7):720-4. doi: 10.1093/neuonc/noq010. Epub 2010 Feb 16. Neuro Oncol. 2010. PMID: 20159882 Free PMC article. Clinical Trial.
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.
Patrij K, Reiser M, Wätzel L, Pels H, Kowoll A, Herrlinger U, Engert A, Linnebank M, Schackert G, Vogt-Schaden M, Egerer G, Lamprecht M, Batchelor TT, Schlegel U, Schmidt-Wolf IG; International Primary CNS Lymphoma Collaborative Group (IPCG). Patrij K, et al. Among authors: vogt schaden m. Ger Med Sci. 2011;9:Doc11. doi: 10.3205/000134. Epub 2011 May 2. Ger Med Sci. 2011. PMID: 21698087 Free PMC article.
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma.
Seidel S, Pels H, Schlömer S, Kowoll A, Fliessbach K, Engert A, Vogt-Schaden M, Egerer G, Reichmann H, Schackert G, Kroschinsky F, Deckert M, Herrlinger U, Klockgether T, Fimmers R, Bode U, Schmidt-Wolf IGH, Schlegel U. Seidel S, et al. Among authors: vogt schaden m. Neurology. 2020 Dec 8;95(23):e3138-e3144. doi: 10.1212/WNL.0000000000010949. Epub 2020 Sep 28. Neurology. 2020. PMID: 32989105 Free PMC article. Clinical Trial.
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
Linnebank M, Moskau S, Jürgens A, Simon M, Semmler A, Orlopp K, Glasmacher A, Bangard C, Vogt-Schaden M, Urbach H, Schmidt-Wolf IG, Pels H, Schlegel U. Linnebank M, et al. Among authors: vogt schaden m. Neuro Oncol. 2009 Feb;11(1):2-8. doi: 10.1215/15228517-2008-082. Epub 2008 Sep 19. Neuro Oncol. 2009. PMID: 18806228 Free PMC article.
30 results